Alzheimer's Disease News and Research

RSS

Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.

Alzheimer's and Parkinson's under the microscope

A detailed discussion by top researches in the field into current Alzheimer's and Parkinson's research features as article of the month in the prestigious journal, Nature Reviews Neuroscience.

24 Jun 2008

Neurological assessment of older adults should become routine examinations

Standard neurological exams of older adults are good predictors of future brain health and quality of life. These tests should become part of the physician's routine examination of older adults say faculty from the Indiana University Center for Aging Research in an editorial in the June 23, 2008 issue of the Archives of Internal Medicine.

24 Jun 2008

Automated magnetic resonance imaging technique assists in earlier Alzheimer's diagnosis

An automated system for measuring brain tissue with magnetic resonance imaging (MRI) can help physicians more accurately diagnose Alzheimer's disease at an earlier stage according to a new study published in the July issue of the journal Radiology.

24 Jun 2008

Top scientists say 'NHS won't survive next 20 years'

In an open letter to the Health Secretary Alan Johnson, a coalition of leading scientists, including Professor Seth Love at Bristol University, slammed the government's underinvestment in dementia research amid warnings of "catastrophic" economic consequences.

19 Jun 2008

Early detection of Alzheimer's in the pipeline

A boost of $1.6 million for new research into Alzheimer's Disease for Australian scientists means that the early detection of the disease could well be in the pipeline.

19 Jun 2008

New drug offers hope for Alzheimer's victims

An experimental drug to treat Alzheimer's Disease has been seen to be effective in trials with Alzheimer's patients.

18 Jun 2008

Polyphenolics derived from red grapes may help treat Alzheimer's disease

Mount Sinai researchers have discovered that polyphenolics derived from red grape seeds may be useful agents to prevent or treat Alzheimer's disease (AD).

17 Jun 2008

Life expectancy in U.S. reached record high of 78.1 years in 2006

Life expectancy for U.S. residents reached a record high of 78.1 years in 2006, compared with a previous record high of 77.8 years in 2005, according to a preliminary report released on Wednesday by the National Center for Health Statistics at CDC, the Washington Post reports. For the report, Melonie Heron, a NCHS demographer, and colleagues analyzed 95% of the death certificates collected in the 50 states and Washington, D.C., in 2006.

17 Jun 2008

Molecular imaging helps follow the progression of Alzheimer's disease

In the past, physicians were able only to follow the progression of Alzheimer's disease (AD) through careful clinical histories, noting the often subtle changes associated with cognitive decline over a number of years.

16 Jun 2008

ExpIND process speeds Alzheimer's drug research

Researchers are actively cutting the time and cost it normally takes to develop radiopharmaceuticals by taking advantage of "Exploratory Investigational New Drug" (ExpIND), an FDA-sanctioned procedure that enhances post-discovery drug development while observing scientific and patient safety standards.

16 Jun 2008

Discovery of mechanisms that direct cholinergic synapse assembly between neurons in vivo

Rapid information processing in the nervous system requires synapses, specialized contact sites between nerve cells and their targets. One particular synapse type, cholinergic, uses the chemical transmitter acetylcholine to communicate between nerve cells. Cholinergic synapses are essential for normal learning and memory, arousal, attention, and all autonomic (involuntary) nervous system functions.

16 Jun 2008

University of California, San Francisco embraces web 2.0 for health information

YouTube and The University of California, San Francisco (UCSF) today launched a comprehensive Internet video channel dedicated to the improved understanding of incurable neurodegenerative brain diseases.

16 Jun 2008

Unique brain maps to assist surgery and research

Researchers from the Howard Florey Institute in Melbourne are developing new technology to create individualised brain maps that will revolutionise diagnosis of disease and enhance the accuracy of brain surgery.

16 Jun 2008

Age-adjusted death rates in U.S. down sharply in 2006

Age-adjusted death rates in the United States dropped significantly between 2005 and 2006 and life expectancy hit another record high, according to preliminary death statistics released today by CDC's National Center for Health Statistics.

11 Jun 2008

Researchers find gamma-secretase modulators being tested for Alzheimer’s work in unexpected and beneficial ways

Researchers at Mayo Clinic, with their national and international collaborators, have discovered how a class of agents now in testing to treat Alzheimer's disease work, and say they may open up an avenue of drug discovery for this disease and others.

11 Jun 2008

Good sleep patterns paramount to health in older men

It appears that disrupted rest and activity rhythms are associated with increased mortality rates among older men, according to new University of Minnesota research.

11 Jun 2008

Australian researchers find important piece of Alzheimer's puzzle

Queensland Brain Institute (QBI) neuroscientists at UQ have discovered a new way to reduce neuronal loss in the brain of a person with Alzheimer's disease.

11 Jun 2008

Memory loss linked to sleep apnea

For the first time, UCLA researchers have discovered that people with sleep apnea show tissue loss in brain regions that help store memory.

11 Jun 2008

European research project to explore Alzheimer's diagnosis

VTT Technical Research Centre of Finland, GE Healthcare, a division of the General Electric Company (NYSE: GE) and a Consortium of leading research institutions across Europe announced the PredictAD project, a research collaboration aimed at developing new diagnostic procedures for patients with Alzheimer's disease.

10 Jun 2008

Genetic variation linked to earlier onset of Alzheimer's symptoms

Investigators at Washington University School of Medicine in St. Louis have identified a genetic variation associated with an earlier age of onset in Alzheimer's disease.

9 Jun 2008